Suntory Beverage & Food Great Britain and Ireland (SBF GB&I), the company behind Ribena, has announced a significant £920,000...
Read MoreExonate has announced plans to advance its lead candidate, EXN407, into a Phase 2b clinical trial for non-proliferative diabetic...
Read MoreEisai has unveiled compelling new clinical data demonstrating that patients with early Alzheimer’s disease can experience sustained benefits from...
Read MoreKling Bio has announced a major step forward in the field of antibody discovery, unveiling a new collaboration and...
Read MoreIn a move that strengthens its position as a comprehensive foodservice provider, Harlech Foodservice has officially taken over North...
Read MoreAkari Therapeutics has reaffirmed its strategic focus on developing its novel PH1 spliceosome modulator payload, a promising innovation in...
Read More